CIK 0001770787 · Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455614458
- Phone
- (925) 401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,700 | $49.43 | $84K | 850,381 |
| 2024-02-09 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,000 | $49.53 | $50K | 855,381 |
| 2024-01-16 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −2,965 | $45.10 | $134K | 857,416 |
| 2024-01-16 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,035 | $45.65 | $47K | 856,381 |
| 2023-12-28 | Hindson Benjamin J. See Remarks | Option exercise | +8,334 | $11.48 | $96K | 285,672 |
| 2023-12-28 | Hindson Benjamin J. See Remarks | Option exercise · Stock Option (right to buy) | −8,334 | 14,978 | ||
| 2023-12-27 | Saxonov Serge Chief Executive Officer | Option exercise | +14,935 | $1.20 | $18K | 860,381 |
| 2023-12-27 | Saxonov Serge Chief Executive Officer | Option exercise · Stock Option (right to buy) | −14,935 | 79,463 | ||
| 2023-12-14 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −300 | $54.39 | $16K | 847,146 |
| 2023-12-14 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,700 | $55.15 | $94K | 845,446 |
| 2023-11-24 | Saxonov Serge Chief Executive Officer | Sale | −3,723 | $43.72 | $163K | 847,446 |
| 2023-11-22 | Wilbur James Chief Commercial Officer | Sale | −3,464 | $43.34 | $150K | 83,342 |
| 2023-11-22 | Hindson Benjamin J. See Remarks | Sale | −3,449 | $43.34 | $149K | 277,338 |
| 2023-11-22 | McAnear Justin J. Chief Financial Officer | Sale | −1,679 | $43.34 | $73K | 97,105 |
| 2023-11-22 | Saxonov Serge Chief Executive Officer | Sale | −3,757 | $43.34 | $163K | 851,169 |
| 2023-11-20 | Wilbur James Chief Commercial Officer | Sale | −14,718 | $42.09 | $619K | 86,806 |
| 2023-11-14 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −2,000 | $39.52 | $79K | 854,926 |
| 2023-10-17 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,979 | $39.51 | $78K | 856,926 |
| 2023-10-16 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −21 | $39.50 | $830 | 858,905 |
| 2023-09-14 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,920 | $49.35 | $95K | 862,173 |
Page 7 of 8 · 142 trades